U.S. flag

An official website of the United States government

NM_003280.3(TNNC1):c.430A>G (p.Asn144Asp) AND multiple conditions

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 30, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000471611.16

Allele description [Variation Report for NM_003280.3(TNNC1):c.430A>G (p.Asn144Asp)]

NM_003280.3(TNNC1):c.430A>G (p.Asn144Asp)

Gene:
TNNC1:troponin C1, slow skeletal and cardiac type [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p21.1
Genomic location:
Preferred name:
NM_003280.3(TNNC1):c.430A>G (p.Asn144Asp)
Other names:
p.N144D:AAC>GAC
HGVS:
  • NC_000003.12:g.52451415T>C
  • NG_008963.1:g.7627A>G
  • NG_033112.1:g.908T>C
  • NM_003280.3:c.430A>GMANE SELECT
  • NP_003271.1:p.Asn144Asp
  • LRG_378t1:c.430A>G
  • LRG_378:g.7627A>G
  • NC_000003.11:g.52485431T>C
  • NM_003280.2:c.430A>G
Protein change:
N144D
Links:
dbSNP: rs730881061
NCBI 1000 Genomes Browser:
rs730881061
Molecular consequence:
  • NM_003280.3:c.430A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Dilated cardiomyopathy 1Z (CMD1Z)
Identifiers:
MONDO: MONDO:0012745; MedGen: C2678475; Orphanet: 154; OMIM: 611879
Name:
Hypertrophic cardiomyopathy 13
Synonyms:
Familial hypertrophic cardiomyopathy 13; TNNC1-Related Familial Hypertrophic Cardiomyopathy
Identifiers:
MONDO: MONDO:0013195; MedGen: C2750472; OMIM: 613243

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000550242Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 30, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.

Robyns T, Kuiperi C, Breckpot J, Devriendt K, Souche E, Van Cleemput J, Willems R, Nuyens D, Matthijs G, Corveleyn A.

Eur J Hum Genet. 2017 Dec;25(12):1313-1323. doi: 10.1038/s41431-017-0004-3. Epub 2017 Oct 10.

PubMed [citation]
PMID:
29255176
PMCID:
PMC5865127

Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.

Lu C, Wu W, Liu F, Yang K, Li J, Liu Y, Wang R, Si N, Gao P, Liu Y, Zhang S, Zhang X.

J Transl Med. 2018 Aug 30;16(1):241. doi: 10.1186/s12967-018-1605-5.

PubMed [citation]
PMID:
30165862
PMCID:
PMC6117967
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000550242.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 144 of the TNNC1 protein (p.Asn144Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with dilated cardiomyopathy and/or hypertrophic cardiomyopathy (PMID: 29255176, 30165862, 30847666, 31513939, 32880476). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 181567). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024